UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 217

Sortiert nach

Potent, orally absorbed glucagon receptor antagonists

Bioorganic & medicinal chemistry letters, 1999-03, Vol.9 (5), p.641-646

1999

Link zum Volltext

Verfügbarkeit prüfen

Substituted Imidazoles as Glucagon Receptor Antagonists

Bioorganic & medicinal chemistry letters, 2001-09, Vol.11 (18), p.2549-2553

2001

Link zum Volltext

Verfügbarkeit prüfen

Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345

Nature (London), 1993-03, Vol.362 (6418), p.350-353

1993

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor

Molecular pharmacology, 1992-09, Vol.42 (3), p.458-463

1992

Link zum Volltext

Verfügbarkeit prüfen

An Orally Active, Water-Soluble Neurokinin-1 Receptor Antagonist Suitable for Both Intravenous and Oral Clinical Administration

Journal of medicinal chemistry, 2001-11, Vol.44 (24), p.4296-4299

2001

Link zum Volltext

Verfügbarkeit prüfen

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Science (American Association for the Advancement of Science), 1998-09, Vol.281 (5383), p.1640-1645

1998

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

European journal of pharmacology, 1997-05, Vol.326 (2-3), p.201-209

1997

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor

The Journal of biological chemistry, 1994-03, Vol.269 (9), p.6587-6591

1994

Link zum Volltext

Verfügbarkeit prüfen

N-Heteroaryl-2-phenyl-3-(benzyloxy)piperidines: A Novel Class of Potent Orally Active Human NK1 Antagonists

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.2907-2914

1996

Link zum Volltext

Verfügbarkeit prüfen

The role of histidine 265 in antagonist binding to the neurokinin-1 receptor

The Journal of biological chemistry, 1994-01, Vol.269 (4), p.2728-2732

1994

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs)

Journal of cellular physiology, 1990-08, Vol.144 (2), p.244-253

1990

Link zum Volltext

Verfügbarkeit prüfen

Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors

Molecular pharmacology, 1992-06, Vol.41 (6), p.1096-1099

1992

Link zum Volltext

Verfügbarkeit prüfen

High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template

Bioorganic & medicinal chemistry letters, 1998-06, Vol.8 (11), p.1343-1348

1998

Link zum Volltext

Verfügbarkeit prüfen

The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor

The Journal of biological chemistry, 1990-09, Vol.265 (26), p.15648-15652

1990

Link zum Volltext

Verfügbarkeit prüfen

Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists

The Journal of biological chemistry, 1994-05, Vol.269 (21), p.14957-14961

1994

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of a Substance P Antagonist with a Somatostatin Scaffold: Factors Affecting Agonism/Antagonism at GPCRs and the Role of Pseudosymmetry

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3827-3831

2000

Link zum Volltext

Verfügbarkeit prüfen

Receptor for Motilin Identified in the Human Gastrointestinal System

Science (American Association for the Advancement of Science), 1999-06, Vol.284 (5423), p.2184-2188

1999

Link zum Volltext

Verfügbarkeit prüfen

Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs

Endocrinology (Philadelphia), 1992-08, Vol.131 (2), p.890-895

1992

Link zum Volltext

Verfügbarkeit prüfen

Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity

The Journal of biological chemistry, 1990-07, Vol.265 (21), p.12210-12216

1990

Link zum Volltext

Verfügbarkeit prüfen

The C Region of Human Insulin-like Growth Factor (IGF) I Is Required for High Affinity Binding to the Type 1 IGF Receptor

The Journal of biological chemistry, 1989-07, Vol.264 (19), p.11004-11008

1989

Link zum Volltext

Verfügbarkeit prüfen

Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom

The Journal of biological chemistry, 1988-07, Vol.263 (21), p.10192-10197

1988

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression

Endocrinology (Philadelphia), 1998-12, Vol.139 (12), p.4920-4927

1998

Link zum Volltext

Verfügbarkeit prüfen

The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention

Current Opinion in Chemical Biology, 2000-08, Vol.4 (4), p.420-427

2000

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Potent Cyclic Hexapeptide NK-1 Antagonists. Use of a Minilibrary in Transforming a Peptidal Somatostatin Receptor Ligand into an NK-1 Receptor Ligand via a Polyvalent Peptidomimetic

Journal of medicinal chemistry, 1996-06, Vol.39 (13), p.2441-2448

1996

Link zum Volltext

Verfügbarkeit prüfen

Serine derived NK1 antagonists 2 : A pharmacophore model for arylsulfonamide binding

Bioorganic & medicinal chemistry letters, 1998-07, Vol.8 (14), p.1851-1856

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(196)

Publikationsform

Artikel
(217)

Sprache

Englisch
(217)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Life Sciences & Biomedicine
(109)
Animals
(108)
Biological And Medical Sciences
(100)
Humans
(91)
Medical Sciences
(64)
Structure-Activity Relationship
(59)
Pharmacology & Pharmacy
(58)
Pharmacology. Drug Treatments
(55)
Rats
(50)
Cricetinae
(45)
Chemistry, Medicinal
(43)
Cho Cells
(39)
Male
(39)
Fundamental And Applied Biological Sciences. Psychology
(36)
Neuropharmacology
(35)
Chemistry
(33)
Neurokinin-1 Receptor Antagonists
(33)
Amino Acid Sequence
(32)
Molecular Sequence Data
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potent, orally absorbed glucagon receptor antagonists

Substituted Imidazoles as Glucagon Receptor Antagonists

Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345

Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor

An Orally Active, Water-Soluble Neurokinin-1 Receptor Antagonist Suitable for Both Intravenous and Oral Clinical Administration

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor

N-Heteroaryl-2-phenyl-3-(benzyloxy)piperidines: A Novel Class of Potent Orally Active Human NK1 Antagonists

The role of histidine 265 in antagonist binding to the neurokinin-1 receptor

Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs)

Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors

High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template

The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor

Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists

Synthesis of a Substance P Antagonist with a Somatostatin Scaffold: Factors Affecting Agonism/Antagonism at GPCRs and the Role of Pseudosymmetry

Receptor for Motilin Identified in the Human Gastrointestinal System

Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs

Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity

The C Region of Human Insulin-like Growth Factor (IGF) I Is Required for High Affinity Binding to the Type 1 IGF Receptor

Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression

The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention

Synthesis of Potent Cyclic Hexapeptide NK-1 Antagonists. Use of a Minilibrary in Transforming a Peptidal Somatostatin Receptor Ligand into an NK-1 Receptor Ligand via a Polyvalent Peptidomimetic

Serine derived NK1 antagonists 2 : A pharmacophore model for arylsulfonamide binding

Suchergebnisse filtern